Adverse Events During Immunotherapy Against Grass Pollen‐Induced Allergic Rhinitis – Differences Between Subcutaneous and Sublingual Treatment

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 73-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sublingual Immunotherapy for Allergic Rhinoconjunctivitis – The Seeming and the Real

By  

International Archives of Allergy and Immunology, Vol. 137, Iss. 3, 2005-07 ,pp. : 181-186

Karger

Access to resources Recommend Favorite

ASCIA‐P51: SAFETY OF 300IR 5‐GRASS POLLEN SUBLINGUAL TABLET FOR THE TREATMENT OF GRASS POLLEN‐INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS AND PEDIATRIC SUBJECTS WITH INTERMITTENT ASTHMA

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. S4, 2016-09 ,pp. : 20-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 120, Iss. 3, 1999-11 ,pp. : 218-224

Karger

Access to resources Recommend Favorite

Safety of sublingual immunotherapy started during the pollen season

By Ariano Renato   Incorvaia Cristoforo   La Grutta Stefania   Marcucci Francesco   Pajno Giovanbattista   Sensi Laura   Di Cara Giuseppe   Sieber Jochen   Yacoub Mona-Rita   Frati Franco  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 103-107

Informa Healthcare

Access to resources Recommend Favorite